New Endocrine and Targeted Agents for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

New Endocrine and Targeted Agents for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Maria Theodoulou, MD

Disclosure

Maria Theodoulou, MD discloses no such relationships exist

Accreditation

NA